Latest Resources

8 March 2022

Coalition demands a ban of Bt Cowpea in Nigeria and neighbouring West African countries

A coalition of non-governmental organisations, farmer groups and research experts from various African countries call on the Nigerian government to revoke the permits granted by Nigeria’s National Biosafety Management Agency (NBMA) to the Institute for Agricultural Research (IAR), Zaria, for the commercial release of genetically modified (Bt) Cowpea (PBR-Cowpea). This call was made yesterday in […]

28 April 2021

Bayer breathing life into Gates’ failed GM drought tolerant maize

Agrarian extractivism continues unabated on the African continent In this alert, African Centre for Biodiversity (ACB) research and advocacy officers, Sabrina Masinjila and Rutendo Zendah, give insights into the development of a double stacked drought tolerant variety MON 87460 x MON 810, under the Gate’s funded project, Water Efficient Maize for Africa (WEMA), now known […]

23 April 2021

Regulator’s blind eye of Corteva’s toxic spread: 2,4-D GM maize and agrarian extractivism in Sout...

It is incontestable that 2,4-D is extremely toxic for the environment and human health, as numerously raised and resisted by civil society for more than a decade. However, a succession of South African regulators over the years have failed to stop 2,4-D from entering our agricultural and food system, in a global context where many […]

18 March 2021

Objection to commodity clearance of Pioneer Hi-Bred RSA GM soybean DAS-814419-2 x DAS-44406-6

Despite the grave warnings of the COVID 19 pandemic and the increased need to de-colonise and de-corporatise our food systems and shift towards sovereignty, there continues to be an increase in the applications for genetically modified organisms (GMOs) of the 2,4-D variety, for introduction into the South African farming and food system. This trend is […]

22 January 2021

Tanzania cancels GMO trials again: Urgent need to uphold ban, disrupt false solutions and neo-col...

In a totally unexpected move, the newly appointed Tanzania Agricultural Minister, Prof Adolf Mkenda, in mid-January 2021 announced the cancellation of research trials involving genetically modified organisms (GMOs) in the country and the decision to put in place extra biosafety scrutiny of imported genetically modified (GM) seed. The decision was taken by the Minister in […]

2 September 2020

Push back against risky and unsafe RNAi GM cassava cultivation in Kenya

An unproven genetically modified (GM) RNAi cassava variety is yet another staple food crop, after maize and banana, on the biotech industry’s agenda for commercial cultivation in Kenya. The brazen lack of safety tests contained in the Kenya Agricultural and Livestock Research Organisation’s (KARLO’s) application for cultivation, and disregard for adherence to biosafety best practise […]

18 August 2020

Objection to commodity clearance of Corteva’s MON 89034 x TC1507 x MIR162 x NK603 x DAS-40278-9 m...

ACB’s objection to commodity clearance of Corteva’s MON 89034 x TC1507 x MIR162 x NK603 x DAS-40278-9 maize The COVID-19 pandemic shines a light exposing the fragility of South Africa’s unequal and unjust food system. A food system that continues to choose herbicides over health, and profit over people and our planet. Since the pandemic, […]

3 August 2020

GMOs in South Africa 23 years on: failures, biodiversity loss and escalating hunger

Transition to agroecology urgently needed This paper aims to update the public on activities and increased concerns since South Africa first approved the cultivation of genetically modified (GM) crops before the turn of the century. We are now living through a global pandemic, pointing to the imbalanced relationship between humans and our life-supporting systems and […]

10 June 2020

ACB raises concerns on GM Covid-19 vaccine trials for SA, calls for transparency & public he...

Clique aqui para a versão portuguesa Por favor, haga clic aquí para el español The African Centre for Biodiversity (ACB) has made a submission to the Registrar of GMOs in South Africa, following an application made by Professor Shabir Ahmed Madhi, from the Respiratory and Meningeal Pathogens Research Unit (RMPRU), Chris Hani Baragwanath Academic Hospital, […]

20 April 2020

COVID-19: Access to medicine & implications for Africa

ACB brings you a new discussion paper Passer à la version française Clique aqui para a versão portuguesa Dear Friends and Colleagues, Expeditious and affordable access to medicines and other healthcare items will be critical to reducing the toll of COVID-19 in Africa. But if nothing is done to compel corporations to make their patents […]